Background A subset of patients with severe COVID-19 develop a hyperinflammatory
syndrome, which might contribute to morbidity and mortality. This study explores a specific …

P300/CBP-associated factor (PCAF) and general control nonderepressible 5 (GCN5) are
closely related epigenetic proteins, each containing an acetyltransferase domain and a …

Multiple sclerosis (MS) is a chronic neurological disease driven by autoimmune, inflammatory
and neurodegenerative processes leading to neuronal demyelination and subsequent …

The liver X receptor (LXR) is a key transcriptional regulator of cholesterol, fatty acid, and
phospholipid metabolism. Dynamic remodeling of immunometabolic pathways, including lipid …

IL-18 is a member of the IL-1 family involved in innate immunity and inflammation.
Deregulated levels of IL-18 are involved in the pathogenesis of multiple disorders including …

Background Cardiovascular disease is a leading cause of mortality in patients with juvenile-onset
systemic lupus erythematosus (JSLE). Traditional factors for cardiovascular risk (CVR) …

Objective: Patients with systemic lupus erythematosus (SLE) have an increased risk of
developing cardiovascular disease. Standard serum lipid measurements in clinical practice do …

It is well established that cholesterol and glycosphingolipids are enriched in the plasma
membrane (PM) and form signaling platforms called lipid rafts, essential for T-cell activation and …

Background: Neutralizing anti-drug antibodies (ADA) can greatly reduce the efficacy of
biopharmaceuticals used to treat patients with multiple sclerosis (MS). However, the biological …

Accelerated atherosclerosis is a complication of the autoimmune rheumatic disease systemic
lupus erythematosus (SLE). We questioned the role played by invariant natural killer T (…